Published in Medical Device Business Week, April 28th, 2004
The feasibility clinical trial is designed to demonstrate the safety and effectiveness of the company's tissue repair cells (TRCs) to regenerate new, healthy bone in the repair of non-union large bone fractures.
Aastrom's TRCs will be combined with a commercial synthetic matrix and used to treat up to five patients,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week